Alpa Laboratories (NSE:ALPA) Total Liabilities: ₹559 Mil (As of Mar. 2026)


NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
74 GF Score
Price ₹67.80
GF Value ₹92.88
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Alpa Laboratories Total Liabilities?

Alpa Laboratories NSE:ALPA -0.82% 74 Total Liabilities is ₹559 Mil as of Mar. 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 74/100 and a GF Value™ of ₹92.88 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Alpa Laboratories's Total Liabilities for the quarter that ended in Mar. 2026 was ₹559 Mil.

Alpa Laboratories's quarterly Total Liabilities declined from Sep. 2025 (₹543.14 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹558.64 Mil).

Alpa Laboratories's annual Total Liabilities increased from Mar. 2024 (₹304.62 Mil) to Mar. 2025 (₹511.94 Mil) and increased from Mar. 2025 (₹511.94 Mil) to Mar. 2026 (₹558.64 Mil).

Alpa Laboratories Total Liabilities Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Total Liabilities Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 335.08 326.92 304.62 511.94 558.64

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 511.94 0.00 543.14 0.00 558.64
NSE:ALPA
74GF Score
Alpa Laboratories Ltd NSE:ALPA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alpa Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=525.274+(0+33.364
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=559

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=2421.447-1862.809
=559

Alpa Laboratories's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=525.274+(0+33.364
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=559

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2421.447-1862.809
=559

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹559 Mil mean?
Alpa Laboratories (NSE:ALPA) has a Total Liabilities of ₹559 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alpa Laboratories and its competitors.
Is Alpa Laboratories' Total Liabilities too high?
Alpa Laboratories' current Total Liabilities is ₹559 Mil. Overall, Alpa Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Total Liabilities compare to ZTS and UTHR?
Alpa Laboratories' Total Liabilities of ₹559 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alpa Laboratories and its competitors. Alpa Laboratories's current Total Liabilities is ₹559 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.88, compared to a current price of ₹67.80 — trading 27% below its estimated fair value. The current Total Liabilities is ₹559 Mil. Alpa Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Total Liabilities is ₹559 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹67.80 is trading 27% below its estimated GF Value™ of ₹92.88. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • Total Liabilities: ₹559 Mil
  • GF Value™: ₹92.88 vs. price of ₹67.80 (27% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
74GF Score

Get the complete analysis for NSE:ALPA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.80
Price
₹92.88
GF Value